巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    West Pharmaceutical Services

    WST
    321.000
    15.500
    5.07%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・West Pharmaceutical Services - 延遲價格・最後更新於 27/05 12:14
    最高位
    321.310
    最低位
    308.500
    開市價
    --
    前收市價
    305.500
    成交量(千)
    17.79
    成交額(百萬)
    48.04
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    23,778.27
    市盈率
    35.790
    息率
    0.23%
    差價
    --
    52週高低
    475.350 - 288.120
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    West Pharmaceutical Services
    證券代碼
    WST.US
    所屬板塊
    Medical Instruments & Supplies
    公司業務
    West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
    發行量
    74281589
    公司總部
    530 Herman O. West Drive
    公司網址
    https://www.westpharma.com
    公司電郵
    Quintin.Lai@westpharma.com
    公司電話
    +1 610 594-2900
    暫無內容

    關於

    West Pharmaceutical Services(WST.US)所屬的行業板塊為Medical Instruments & Supplies。
    West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
    截至27/05 12:14:59,West Pharmaceutical Services的股價升5.07,市值23,778.27百萬。West Pharmaceutical Services的市盈率及息率分別為35.790及0.23%。
    詳細公司背景可參考: https://www.westpharma.com